Session Information
-
WCLC 2021
2021 World Conference on Lung Cancer
Presentation Date(s):- September 8 - 14, 2021
- Total Presentations: 1107
All times listed are in Mountain Time MDT (UTC-6:00)
PL - Plenary
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
FP - Featured Posters
P - Posters
WS - Workshops
IS - Industry Symposium
MTE - Meet the Expert
BEDG - Brain Exchange Discussion Groups
September 8 Wed
Sep 8 Thursday
September 9 Thu
Sep 9 Friday
September 10 Fri
Sep 10 Saturday
September 11 Sat
Sep 11 Sunday
September 12 Sun
Sep 12 Monday
September 13 Mon
Sep 13 Tuesday
September 14 Tue
Sep 14
-
+
P01 - Early Stage/Localized Disease/Ablative Therapies - Adjuvant Therapy
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Early Stage/Localized Disease/Ablative Therapies
-
+
P01.01 - LIBRETTO-432: A Placebo-Controlled Phase 3 Study of Adjuvant Selpercatinib in Stage IB-IIIA RET Fusion-Positive NSCLC
00:00 - 00:00 | Presenter: Jonathan Goldman
- Abstract
Loading...
-
+
P53 - Novel Therapeutics and Targeted Therapies - Others
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Novel Therapeutics and Targeted Therapies
-
+
P53.02 - Efficacy and Safety of Larotrectinib in Patients With Tropomyosin Receptor Kinase (TRK) Fusion-Positive Lung Cancer
00:00 - 00:00 | Presenter: Alexander Drilon
- Abstract
Loading...
-
+
IS10 - Satellite CME Symposium by Research To Practice: Expert Second Opinion: Investigators Discuss Available Clinical Research in the Care of Patients with Non-Small Cell Lung Cancer and Validated Targets Beyond EGFR
- 05:45 - 06:45
- 9/10/2021
- Location: Program Auditorium
- CME Accredited by Other Provider
- Type: Satellite CME Symposia
- Track: N.A.
- Moderators:D. Ross Camidge, Justin Gainor, Neil Love, Alexander Drilon
-
+
IS10.01 - MODULE 1: Selection and Sequencing of Therapy for Patients with Non-Small Cell Lung Cancer (NSCLC) and an ALK Rearrangement
05:45 - 06:00
- Abstract
No abstract available for this presentation
-
+
IS10.02 - MODULE 2: Current and Future Directions in the Management of ROS1-Positive NSCLC
06:00 - 06:15
- Abstract
No abstract available for this presentation
-
+
IS10.03 - MODULE 3: Optimal Use of Recently Approved RET Inhibitors in the Care of Patients with RET-Positive NSCLC
06:15 - 06:30
- Abstract
No abstract available for this presentation
-
+
IS10.04 - MODULE 4: Rational Approaches to Targeting MET Abnormalities for Patients with NSCLC
06:30 - 06:45
- Abstract
No abstract available for this presentation
-
+
OA17 - Multidisciplinary Care of Thoracic Oncology Patients During COVID-19 Pandemic
- 20:00 - 21:00
- 9/12/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Oral
- Track: Nursing and Allied Health Professionals
- Moderators:Sara McLaughlin-Barrett
-
+
OA17.04 - The Global Impact of COVID-19 on Telehealth and Care for Persons With Thoracic Cancers
20:30 - 20:40 | Presenter: Anne-Marie Baird
- Abstract
Loading...
